Management board

Alban Bessede Explicyte Immuno Oncology CEO immusmol

Holding a specific expertise in cancer immunotherapy models, Alban (also CEO of ImmuSmol) actively contributes to the design and discussion of clients' studies.

Alban Bessede, PhD
Immunologist - Scientific Director
pubmed publications explicyte
Loic Cerf fluofarma explicyte immuno oncology

Having managed preclinical studies for over 10 years, Loïc is in charge of customer relations, ensuring the planning, day-to-day coordination and reporting of clients' studies.

Loïc Cerf, MSc
Global Project Manager
Francois Ichas Fluofarma Inserm Explicyte Immuno-Oncology

Chief Scientific Officer of a preclinical CRO for 15 years, François brings expertise in oncology & high-content analysis technologies.

François Ichas, PhD
Scientific Advisor
pubmed publications explicyte

Scientific collaborators

Francesca Fallarino immunologist tryptophan metabolism

Francesca Fallarino, Associate Professor at University of Perugia, Department of Experimental Medicine, Perugia, Italy

Francesca Fallarino, PhD
Immunologist, University of Perugia
pubmed publications explicyte
Antoine Italiano

Head of the Early Phase Trials and Sarcoma Units at the Bergonié Comprehensive Cancer Center in Bordeaux, France.

Antoine Italiano, MD, PhD
Medical oncologist, Institut Bergonié
pubmed publications explicyte